High grade cervical intraepithelial neoplasia positive biopsy: the importance of accurate pre-operative workup.


Journal

Minerva ginecologica
ISSN: 1827-1650
Titre abrégé: Minerva Ginecol
Pays: Italy
ID NLM: 0400731

Informations de publication

Date de publication:
Dec 2020
Historique:
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 20 1 2021
Statut: ppublish

Résumé

In cervical cancer screening programs, women with abnormal cytology and confirmation by biopsy are referred for colposcopy for histological evaluation. We characterized the presence and the genotype of HPV by Linear Array HPV genotyping assay in cytological samples collected from about 400 women undergoing conization, with reported high CIN grade after biopsy. The most prevalent genotype was HPV 16, with an increasing presence depending on the severity of the CIN and with the highest incidence in the 26-35 age range. In the group of younger women (<25) we found the highest percentage of CIN3 (39.3%) and the lowest of CIN1 (17.9%). An increase of CIN1 with increasing age was observed. A different distribution of HPV presence was observed depending on CIN grade (P<0.001): CIN1 HPV negative samples were 46.3%, CIN2: 5.8% and CIN3: 1.4%. Interesting, in the analyzed cohort, we observed the presence of 30% of CIN1. Moreover, within CIN1, 85% of them were associated to negative HPV detection, this observation suggested that the detection of HPV presence may be useful to identify low CIN grade that should be reconsidered for surgical treatment. These findings suggest implementing the protocol for the management of women with high risk precancer lesions, with a further HPV test before surgical treatment. The evaluation of HPV presence and genotype before conization might represent a useful tool in reducing or postpone the conization treatment.

Sections du résumé

BACKGROUND BACKGROUND
In cervical cancer screening programs, women with abnormal cytology and confirmation by biopsy are referred for colposcopy for histological evaluation.
METHODS METHODS
We characterized the presence and the genotype of HPV by Linear Array HPV genotyping assay in cytological samples collected from about 400 women undergoing conization, with reported high CIN grade after biopsy.
RESULTS RESULTS
The most prevalent genotype was HPV 16, with an increasing presence depending on the severity of the CIN and with the highest incidence in the 26-35 age range. In the group of younger women (<25) we found the highest percentage of CIN3 (39.3%) and the lowest of CIN1 (17.9%). An increase of CIN1 with increasing age was observed. A different distribution of HPV presence was observed depending on CIN grade (P<0.001): CIN1 HPV negative samples were 46.3%, CIN2: 5.8% and CIN3: 1.4%. Interesting, in the analyzed cohort, we observed the presence of 30% of CIN1. Moreover, within CIN1, 85% of them were associated to negative HPV detection, this observation suggested that the detection of HPV presence may be useful to identify low CIN grade that should be reconsidered for surgical treatment.
CONCLUSIONS CONCLUSIONS
These findings suggest implementing the protocol for the management of women with high risk precancer lesions, with a further HPV test before surgical treatment. The evaluation of HPV presence and genotype before conization might represent a useful tool in reducing or postpone the conization treatment.

Identifiants

pubmed: 33410312
pii: S0026-4784.20.04587-6
doi: 10.23736/S0026-4784.20.04587-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-419

Auteurs

Cecilia Bussani (C)

Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy - cecilia.bussani@unifi.it.

Francesca Malentacchi (F)

Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Karin L Andersson (KL)

Colposcopy Service, Toscana Centro Unit of Local Health, USL 3, Palagi Hospital, Florence, Italy.

Massimiliano Fambrini (M)

Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Chiara Coco (C)

Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Dora Pavone (D)

Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Giulia Fantappiè (G)

Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Irene Turrini (I)

Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Valeria Dubini (V)

Colposcopy Service, Toscana Centro Unit of Local Health, USL 3, Palagi Hospital, Florence, Italy.

Felice Petraglia (F)

Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Flavia Sorbi (F)

Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH